In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Impaired kidney function related to treatment of childhood cancer does not recover over time, according to a Dutch study reported in Cancer Epidemiology,…
The Women’s Health Initiative launched a hormone therapy trial in the 1990s and follow-up continued with the women participating in the trials. A new study describes the long-term…
By Will Boggs, MD NEW YORK (Reuters Health) – Port-A-Cath-related thrombosis develops in up to 40% of pediatric oncology patients, researchers from Switzerland report. “Children with cancer who…
Open enrollment for the Affordable Care Act begins on October 1st, but are you ready for the new policies to be implemented? How will policy and health coverage…
The United States is not a developing nation, in civil war, in famine, or in drought, yet it is not the healthiest nation. Many of the statistics presented…
More than half of knee replacements are performed on patients under the age of 65. A new study in the Journal of Bone and Joint Surgery examines the cost…
John Kheir, MD, discusses his journey to find a way to oxygenate blood without the use of lungs. Using microparticles injected with oxygen, Kheir and his team were…
As we age, bones become less dense, increasing the risk of hip and other bone fractures. Testing bone mineral density is one way physicians assess a patient’s fracture…
What if it were possible to combine the technological capabilities of an entire laboratory on one single chip? Scientists all across Europe may be getting close. Scientists at…
NEW YORK (Reuters Health) – A novel VEGFR inhibitor, tivozanib, improves progression-free survival significantly in patients with metastatic renal cell carcinoma but does not improve overall survival, according…
